AWARD
A -- Therapeutic Molecule Phenotypic Screening Capability services in support of USAMRIID
- Notice Date
- 9/15/2020 6:57:34 AM
- Notice Type
- Award Notice
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- W4PZ USA MED RSCH ACQUIS ACT FORT DETRICK MD 21702-5014 USA
- ZIP Code
- 21702-5014
- Solicitation Number
- W81XWH-20-C-0132
- Archive Date
- 09/29/2020
- Point of Contact
- Erik Przygocki, Jayme L. Fletcher
- E-Mail Address
-
erik.j.przygocki.civ@mail.mil, jayme.l.fletcher2.civ@mail.mil
(erik.j.przygocki.civ@mail.mil, jayme.l.fletcher2.civ@mail.mil)
- Award Number
- W81XWH-20-C-0132
- Award Date
- 09/14/2020
- Awardee
- GENEVA FOUNDATION, THE Tacoma WA USA
- Award Amount
- 901985.84
- Description
- A firm-fixed price, sole source contract was awarded to The Geneva Foundation under the authority as prescribed in FAR 6.302-1 -- Only one responsible source.� The Geneva Foundation is the only vendor with demonstrated skills, knowledge, and abilities associated with phenotypic drug screening against BSL-3 viral pathogens using the Opera high content imaging system, affiliated liquid handling instruments, and data analysis programs and workflow. Additionally, The Geneva Foundation is the only vendor with active participants in USAMRIID�s BPRP enabling immediate access to the containment suites.� Further, due to the critical need to continue the high content screening capability at USAMRIID, The Geneva Foundation is the only vendor capable of providing the services needed to meet the government�s need.
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/c5ed424ce5ed47aab250ceea02389cf1/view)
- Place of Performance
- Address: Frederick, MD 21702, USA
- Zip Code: 21702
- Country: USA
- Zip Code: 21702
- Record
- SN05797117-F 20200917/200915230147 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |